The feline atopic dermatitis treatment market is projected to grow from USD 5.7 billion in 2025 to USD 8.9 billion by 2035, at a CAGR of 4.5%. Corticosteroids will dominate with a 46.7% market share, while oral will lead the route of administration segment with a 52.3% share.